Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Acrivon Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- +1 vs. Q2 2024
- Shares held
- 23.0M
- +275.9K (+1.2%) vs. Q2 2024
- Total value
- $160.8M
- +$29.2M (+22.2%) vs. Q2 2024
- New holders
- 8
- 17 more added
- Sold out
- 7
- 14 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 46 | $0 | 0.00% | +23+100.0% | Added |
| Capital Advisors, Ltd. LLC | 48 | $0 | 0.00% | 00.0% | Unchanged |
| Avion Wealth | 88 | $0 | 0.00% | 00.0% | Unchanged |
| Capital Performance Advisors LLP | 32 | $224 | 0.00% | +32 | New |
| Sterling Capital Management LLC | 37 | $259 | 0.00% | +37 | New |
| Russell Investments Group, Ltd. | 258 | $1.81K | 0.00% | −911−77.9% | Reduced |
| Federation des caisses Desjardins du Quebec | 400 | $2.80K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 378 | $3.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 695 | $4.87K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 800 | $5.60K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 839 | $5.87K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 856 | $5.99K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,277 | $9.00K | 0.00% | +161+14.4% | Added |
| New York State Common Retirement Fund | 2,314 | $16.2K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 2,581 | $18.1K | 0.00% | +933+56.6% | Added |
| Tower Research Capital LLC (TRC) | 4,755 | $33.3K | 0.00% | +976+25.8% | Added |
| Wells Fargo & Company | 5,422 | $38.0K | 0.00% | +231+4.5% | Added |
| UBS Group AG | 5,662 | $39.6K | 0.00% | −5,490−49.2% | Reduced |
| Corebridge Financial, Inc. | 6,316 | $44.2K | 0.00% | −39−0.6% | Reduced |
| Mirae Asset Global ETFs Holdings Ltd. | 6,471 | $45.3K | 0.00% | −37−0.6% | Reduced |
| AAFCPAs Wealth Management, LLC | 10,678 | $74.7K | 0.04% | 00.0% | Unchanged |
| Citigroup Inc | 11,216 | $78.5K | 0.00% | +6,134+120.7% | Added |
| Marex Group plc | 13,187 | $92.3K | 0.00% | 00.0% | Unchanged |
| American Century Companies Inc | 15,402 | $107.8K | 0.00% | +15,402 | New |
| Rhumbline Advisers | 17,760 | $124.3K | 0.00% | +1,551+9.6% | Added |
| Exchange Traded Concepts, LLC | 20,348 | $142.4K | 0.00% | −22,516−52.5% | Reduced |
| Nuveen Asset Management, LLC | 25,779 | $180.5K | 0.00% | +13,958+118.1% | Added |
| Bank of New York Mellon Corp | 29,509 | $206.6K | 0.00% | −7,123−19.4% | Reduced |
| Bank of America Corp | 29,963 | $209.7K | 0.00% | +2,413+8.8% | Added |
| Trexquant Investment LP | 30,383 | $212.7K | 0.00% | +30,383 | New |
| Dimensional Fund Advisors LP | 30,824 | $215.8K | 0.00% | +20,758+206.2% | Added |
| Barclays PLC | 33,306 | $233.1K | 0.00% | +11,273+51.2% | Added |
| JPMorgan Chase & Co | 33,991 | $237.9K | 0.00% | +28,748+548.3% | Added |
| Morgan Stanley | 35,914 | $251.4K | 0.00% | +18,665+108.2% | Added |
| Prelude Capital Management, LLC | 37,727 | $264.1K | 0.02% | +37,727 | New |
| Millennium Management LLC | 39,750 | $278.3K | 0.00% | +39,750 | New |
| Renaissance Technologies LLC | 45,900 | $321.3K | 0.00% | −8,600−15.8% | Reduced |
| Baker Bros. Advisors LP | 52,885 | $370.2K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 76,981 | $538.9K | 0.01% | +18,800+32.3% | Added |
| UBS Oconnor LLC | 79,249 | $554.7K | 0.01% | −26,000−24.7% | Reduced |
| Northern Trust Corp | 105,398 | $737.8K | 0.00% | −8,655−7.6% | Reduced |
| DAFNA Capital Management LLC | 112,414 | $786.9K | 0.19% | −8,937−7.4% | Reduced |
| Charles Schwab Investment Management Inc | 116,253 | $813.8K | 0.00% | −27,705−19.2% | Reduced |
| Exome Asset Management LLC | 116,757 | $817.3K | 0.55% | +116,757 | New |
| Goldman Sachs Group Inc | 198,168 | $1.39M | 0.00% | +173,784+712.7% | Added |
| State Street Corp | 225,896 | $1.58M | 0.00% | +47,233+26.4% | Added |
| Geode Capital Management, LLC | 302,103 | $2.12M | 0.00% | −6,290−2.0% | Reduced |
| Vanguard Group Inc | 637,538 | $4.46M | 0.00% | −107,972−14.5% | Reduced |
| BlackRock, Inc. | 786,982 | $5.51M | 0.00% | +786,982 | New |
| Marshall Wace, LLP | 809,859 | $5.67M | 0.01% | −139,007−14.6% | Reduced |
| Wellington Management Group LLP | 888,130 | $6.22M | 0.00% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 2,122,605 | $14.9M | 4.18% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,140,628 | $15.0M | 0.02% | +20,982+1.0% | Added |
| Perceptive Advisors LLC | 5,360,858 | $37.5M | 0.81% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 8,340,508 | $58.4M | 0.67% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −659,724−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −30,714−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −17,207−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −12,721−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −12,552−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,493−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −5,080−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |